The erythromycin breath test as a predictor of cyclosporine blood levels

Clinical Pharmacology and Therapeutics
P B WatkinsJ J Voorhees

Abstract

The daily dose of cyclosporine required to attain a desired blood level can vary greatly among patients. Because elimination of cyclosporine depends on its metabolism in the liver by an enzyme (cytochrome P-450IIIA) that also demethylates erythromycin, we reasoned that the ability of patients to demethylate a test dose of erythromycin might be useful in estimating their appropriate daily doses of cyclosporine. Accordingly, the [14C-N-methyl] erythromycin breath test was administered to 32 patients before they received 3.0, 5.0, or 7.5 mg/kg/day cyclosporine to treat psoriasis. We found that a simple mathematical equation incorporating just the 14CO2 production, the age of the patient, and the daily dose of cyclosporine accounted for almost 80% (R2 = 0.78) of the interpatient variability in cyclosporine blood levels we observed. Our data indicate that P-450IIIA activity largely accounts for the relationship between dose of cyclosporine and blood levels for an individual patient. We conclude that the erythromycin breath test may be a convenient guide for cyclosporine dosing.

Citations

May 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Jan 1, 1996·British Journal of Clinical Pharmacology·S M YuleJ R Idle
Mar 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K A Bachmann, L Jauregui
May 23, 1998·Annual Review of Pharmacology and Toxicology·K E Thummel, G R Wilkinson
Jun 29, 1999·The Journal of Pharmacy and Pharmacology·N ShibataA Yamaji
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N YamamotoN Saijo
Aug 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K S Lown, P B Watkins
May 29, 2003·Critical Care Medicine·Curtis E HaasWilliam Reiss
Dec 14, 1999·British Journal of Clinical Pharmacology·K E KenworthyJ B Houston
Jul 23, 2013·Clinical Pharmacokinetics·Frans L OpdamHenk-Jan Guchelaar
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·A ArmuzziA Gasbarrini
Oct 1, 1995·British Journal of Clinical Pharmacology·T TateishiA J Wood
Mar 1, 1997·Clinical Pharmacology and Therapeutics·D DarbarD M Roden
Aug 1, 1996·Therapeutic Drug Monitoring·P B Watkins
Sep 22, 2000·Molecular Pharmacology·L B LanE G Schuetz
Jun 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabiola DelcòStephan Krähenbühl
Jan 16, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D A SmithB C Jones
Jan 1, 1997·Journal of Clinical Pharmacology·K T Kivistö, H K Kroemer
Mar 28, 2001·Journal of Clinical Pharmacology·J B Schwartz
Oct 17, 2001·Pharmacotherapy·C E HaasR C DiCenzo
Jul 17, 2001·Journal of Clinical Pharmacology·R E ArianoD S Sitar
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Eleni V Dimaraki, Craig A Jaffe
Sep 1, 1996·The Journal of Pharmacy and Pharmacology·R A YeatesT Zimmermann
Dec 1, 1995·Clinical Biochemistry·U Christians, K F Sewing
Dec 22, 1999·Journal of Hepatology·S SchenkerA M Hoyumpa
Dec 1, 1992·Trends in Pharmacological Sciences·S CholertonJ R Idle
Feb 1, 1993·Pharmacology & Therapeutics·A K DalyJ R Idle
Feb 1, 1993·Pharmacology & Therapeutics·U Christians, K F Sewing
Jan 1, 1995·Clinical Pharmacology and Therapeutics·K S LownP B Watkins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.